M. Bilal Abid

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

April, 2025

M. Bilal Abid

Mar 5, 2025, 06:49 | Blog

M. Bilal Abid: Impact of Disparity - Navigating Treatment Equality in Cancer Care

M. Bilal Abid, Research Fellow in Cancer Therapeutics at MD Anderson Cancer Center, shared a…

Feb 25, 2025, 14:04 | Blog

M. Bilal Abid: Concluded the PANAO 2025 conference

Bilal Abid, Research Fellow in Cancer Therapeutics at MD Anderson Cancer Center, shared a post…

Feb 21, 2025, 09:39 | Science

M. Bilal Abid: Excited to present at the UT San Antonio MD Anderson Cancer Center

M. Bilal Abid, M. Research Fellow in Cancer Therapeutics at MD Anderson Cancer Center, posted…

Nov 10, 2024, 04:17 | Blog

M. Bilal Abid: Reporting data on the efficacy and safety of bispecific CAR T-cell therapy in hematological malignancies

M. Bilal Abid, Research Fellow in Cancer Therapeutics at MD Anderson Cancer Center, shared on…

Oct 15, 2024, 14:07 | Blog

M. Bilal Abid about development of bispecific antibodies across community practices

M. Bilal Abid posted on LinkedIn: "My vision on broader development of bispecific antibodies across…

All: 5 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023